Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Chemoenzymatic Preparation of Silybin β-Glucuronides and Their Biological Evaluation

Vladimír Kr̆en, Jitka Ulrichová, Pavel Kosina, David Stevenson, Petr Sedmera, Věra Přikrylová, Petr Halada and Vilím šsimánek
Drug Metabolism and Disposition December 2000, 28 (12) 1513-1517;
Vladimír Kr̆en
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jitka Ulrichová
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pavel Kosina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Stevenson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Petr Sedmera
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Věra Přikrylová
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Petr Halada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vilím šsimánek
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Chemoenzymatic glucuronidation of the optically pure silybin A (1) using ovine liver glucuronyl transferase afforded three β-glucuronides of silybin, substituted at phenolic OH groups at the positions C-20 (2), C-7 (3), and C-5 (4) formed in the yields 27, 62.5, and 2.5%, respectively. Using these standards, it was shown that the main silybin conjugate in humans is its 20-β-d-glucuronate (2), while the C-7 regioisomer (3) was formed in lower proportion. The rate of conjugation of (natural) silybin diastereomers 10S, 11S and 10R, 11R, and therefore also their metabolism in humans is rather different. The radical scavenging activity of 2 is considerably lower than that of its aglycone (1); however, the activity of 3 is higher than in the silybin. These findings corroborate the hypothesis that, at physiological pH, the exclusive target for one-electron oxidation of the silybin molecule is theo-methoxy-phenolic structure at C-19, C-20. This is first pharmacological study using optically pure silybin.

Footnotes

  • Send reprint requests to: Vladimı́r Kr̆en, Institute of Microbiology, Academy of Sciences of the Czech Republic, Laboratory of Biotransformation, Vı́deňská 1083, CZ 142 20 Prague 4, Czech Republic. E-mail: kren{at}biomed.cas.cz

  • This work was supported by Grants 303/98/0414 and 303/99/1382 from the Grant Agency of the Czech Republic; Grant PP-Z1/13/96 from Ministry of Industry and Commerce of the Czech Republic; Grant VS 96021, MSM 151100003 from Ministry of Education, Youth and Sport of the Czech Republic; and by New Zealand Foundation for Research Science and Technology Contract C08620.

  • Abbreviations used are::
    UDPGT
    uridine 5′-diphosphoglucuronyl transferase
    DPPH
    1,1-diphenyl-2-picrylhydrazyl radical
    UDPGA
    uridine 5′-diphosphoglucuronic acid trisodium salt
    gCOSY
    gradient-selected correlated spectroscopy
    NOESY
    nuclear Overhauser and exchange spectroscopy
    ROESY
    rotation frame nuclear Overhauser enhancement spectroscopy
    HMQC
    heteronuclear multiple quantum correlation
    HMBC
    heteronuclear multiple bond correlation
    HOM2DJ
    homonuclear J-resolved two-dimensional NMR
    • Received May 22, 2000.
    • Accepted September 14, 2000.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

 

DMD articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 28 (12)
Drug Metabolism and Disposition
Vol. 28, Issue 12
1 Dec 2000
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Chemoenzymatic Preparation of Silybin β-Glucuronides and Their Biological Evaluation
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Chemoenzymatic Preparation of Silybin β-Glucuronides and Their Biological Evaluation

Vladimír Kr̆en, Jitka Ulrichová, Pavel Kosina, David Stevenson, Petr Sedmera, Věra Přikrylová, Petr Halada and Vilím šsimánek
Drug Metabolism and Disposition December 1, 2000, 28 (12) 1513-1517;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Chemoenzymatic Preparation of Silybin β-Glucuronides and Their Biological Evaluation

Vladimír Kr̆en, Jitka Ulrichová, Pavel Kosina, David Stevenson, Petr Sedmera, Věra Přikrylová, Petr Halada and Vilím šsimánek
Drug Metabolism and Disposition December 1, 2000, 28 (12) 1513-1517;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • CYP3A-Catalyzed Deoxycholate and Glycodeoxycholate Oxidation
  • Variants linked with hepatic CYP2D6 expression and activity
  • Cytochrome P450 4F11 in lung cancer
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics